Concepedia

Sven Bischoff

SB

Statistics

Publications

21

Citations

1.7K

H-Index

16

Active since

1996

Affiliations

Charité - Universitätsmedizin Berlin(Current)

University Medical Center Hamburg-Eppendorf

Universität Hamburg

Dermatopathologie Friedrichshafen

Freie Universität Berlin

Sven Bischoff is an author at Charité - Universitätsmedizin Berlin specializing in medicine, oncology, and pancreatic cancer.

ORCID

Publications per year

1996–2023

21

Publications

21

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Helmut Oettle, Hanno Riess, Jens Stieler et al. · Journal of Clinical Oncology · 2014 · 484 citations

, , +13

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Marianne Sinn, Marcus Bahra, Torsten Liersch et al. · Journal of Clinical Oncology · 2017 · 296 citations

, , +13

Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

Uwe Pelzer, Bernhard Opitz, G. Deutschinoff et al. · Journal of Clinical Oncology · 2015 · 266 citations

, , +14

Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.

T. Andus, I. Caesar, Sven Bischoff et al. · PubMed · 1996 · 110 citations

, , +13

Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma

Philipp Lohneis, Marianne Sinn, Sven Bischoff et al. · European Journal of Cancer · 2017 · 87 citations

, , +16

1–5 of 21